Biologics and Biosimilars Regulations and Registration in South Korea
The Korean pharmaceutical market is estimated to be worth $24.3 billion in 2019, and between 2015 and 2019, it grew […]
Biologics
Stay informed on the latest in biologic medicines with Biologics Insights. Explore trends, research updates, regulatory news, and innovations in therapeutic biologics, biosimilars, and advanced biologic treatments.
Biologics and Biosimilars Regulation and Registration in India (CDSCO)
The size of the Indian biosimilars market, which was anticipated to be worth $349 million in 2022, is expected to
Biologics in Autoimmune Diseases: A New Hope for Patients
Autoimmune diseases are complex and diverse, affecting millions of people globally with varying degrees of severity and symptoms. There are
Biosimilar Product Development: Regulatory Challenges & Key Insights
In this era where the demand for affordable healthcare is increasing every day, biosimilars that are replacements for biologics have
Bioconjugates: Combining the Best of Biologics and Small Molecules
Bioconjugates are molecules formed by chemically linking two or more molecules, typically involving a biological molecule like a protein, enzyme,
Biosimilars vs. Generics: Key Differences and Market Implications
In pharmaceuticals, biosimilars and generics are two important categories that often come up in discussions about drug affordability and accessibility.
Import of Biological Specimens into India
A Biological specimen is a pharmaceutical product prepared by utilizing living cells and tissues to prevent, diagnose, or treat diseases.
Registration of Biologics in Malaysia (NPRA)
Biologics have emerged as a significant treatment for various diseases in Malaysia. With their increasing relevance in addressing chronic diseases
Biologics & Biosimilar Regulations in European Union (EU) (EMA)
In Europe, biologics and biosimilars are evaluated through a lens of scientific comparability and public health responsibility. For executives, this